SELLAS Life Sciences Group, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $4.0M | $14.3M |
| Jun 2022 | — | $19.1M | $27.0M |
| Sep 2022 | — | $12.6M | $21.3M |
| Dec 2022 | — | $4.9M | $17.1M |
| Mar 2023 | — | $13.2M | $23.9M |
| Jun 2023 | — | $4.8M | $13.8M |
| Sep 2023 | — | $-3.8M | $4.0M |
| Dec 2023 | — | $-8.0M | $2.5M |
| Mar 2024 | — | $9.7M | $18.4M |
| Jun 2024 | — | $2.9M | $9.1M |
| Sep 2024 | — | $15.9M | $21.0M |
| Dec 2024 | — | $9.5M | $13.9M |
| Mar 2025 | — | $27.8M | $28.4M |
| Jun 2025 | — | $26.1M | $25.3M |
| Sep 2025 | — | $45.6M | $44.3M |
| Dec 2025 | — | $70.9M | $71.8M |
| Mar 2026 | — | $107.4M | $107.1M |
| Jun 2026 | — | $137.7M | $138.3M |